A team in Pittsburgh received a $2.3 million grant to fast-track the development and clinical transition of a minimally ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

The global hydrocephalus shunt market is poised for steady expansion, with Future Market Insights (FMI) projecting a market ...

The 1960s saw the introduction of new surgical approaches. The distal splenorenal shunt (DSRS) was introduced, which selectively decompressed gastroesophageal varices while maintaining portal ...

THE dangers of surgery in patients with liver disease have long been recognized but poorly understood. With the recent development of venous-shunt surgery for the relief of portal hypertension a ...

TA Criterion 1: The Technology Must Have Final Approval From the Appropriate Government Regulatory Bodies. The FDA has approved the following aqueous shunt devices: Ahmed glaucoma valve implant ...

A study involving 20 dogs demonstrated that laparoscopic portosystemic shunt attenuation (LPSSA) is a viable surgical option, particularly for extrahepatic shunts located in the epiploic foramen.

I'm a practicing vet with over 13 years of experience in small animal surgery and medicine and have been a dog owner my ...